Latest filing published 16 Sept 2019 for Immunovia AB, €1,305.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mats Grahn: trading record in brief
All filings by Mats Grahn on record concern Immunovia AB. In total, 4 filings cover trades dated from 14 October 2016 to 12 September 2019.
No open-market sale appears; the market trades are 4 purchases worth €89k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2019 to date brings 2 purchases and no sales.
A typical purchase (the median) is worth €17k.
Most recently, on 16 September 2019, the filings show an open-market purchase worth €1,305 in Immunovia AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 4 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mats Grahn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ SEK 6.950.1% of flowTeckningsoptionFI:csv-8d646d5feabc5ac89a13Canonical exit: 11 Dec 2019 (T+90)
- 17,500 shares@ SEK 7.771.1% of flowTeckningsoptionFI:csv-e0279c62aeaefa9179b1Canonical exit: 28 Sept 2019 (T+90)
- 2,000 shares@ SEK 271.004.6% of flowFI:csv-eacbe9bd833a15523f69Canonical exit: 13 Sept 2018 (T+90)
- 2,425 shares@ SEK 87.001.9% of flowISIN SE0009155336FI:csv-9850c52b6191ef9f2482Canonical exit: 12 Jan 2017 (T+90)
4 of 4 declarations